Form 4 holding
Director
REGENERON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 312,578
- Estimated value
- $297,342,948
- Report date
- 03 Apr 2023
- Price
- $951.26
- Ownership
- Direct
VAGELOS P ROY - Director at REGENERON PHARMACEUTICALS, INC.
Insider Transactions and Holdings
- Entity type
- Company
- Role
- Director
- Issuer symbol
- REGN on Nasdaq
- Source evidence
- Open source filing history
Identity
2 facts
Issuer context
1 fact
SEC evidence
1 fact
There are no Buy or Sell transactions made by VAGELOS P ROY since 01 Jun 2025
Holdings reported by VAGELOS P ROY for REGENERON PHARMACEUTICALS, INC.
Form 4 holding
Director
REGENERON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 125,493
- Estimated value
- $119,376,471
- Report date
- 03 Apr 2023
- Price
- $951.26
- Ownership
- by CLAT
Form 4 holding
Director
REGENERON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 23,461
- Estimated value
- $22,317,511
- Report date
- 03 Apr 2023
- Price
- $951.26
- Ownership
- by Spouse as Trustee
Form 4 holding
Director
REGENERON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 3,609
- Estimated value
- $3,433,097
- Report date
- 03 Apr 2023
- Price
- $951.26
- Ownership
- by trust for grandch
Form 4 holding
Director
REGENERON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 1,963
- Estimated value
- $1,867,323
- Report date
- 03 Apr 2023
- Price
- $951.26
- Ownership
- By 401(k) Plan
Transactions reported by VAGELOS P ROY for REGENERON PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.